The five-year reauthorization of the Federal Aviation Administration (FAA) was signed into law on May 16, 2024. In a big win for allergists and allergy advocacy organizations, the law includes a provision that requires airlines to include epinephrine in a form specifically intended for treating anaphylaxis in all on-board first aid kits on planes.

The American College of Allergy, Asthma and Immunology (ACAAI) and its Advocacy Council have been advocating for this change with Congress for many years.

Source: https://acaai.org